1. Anterior ischemic optic neuropathy (AION) Most common over 50 years Painless monocular over hours to days Visual acuity Visual field APD

3. AION Arteritic AION is associated with giant cell arteries (GCA) Nonarteritic AION

5. AAION Is less frequent 5-10% Older patients (mean 70yr) Inflammatory and thrombotic occlusion post. Cilliary artery Systemic symptoms

6. Systemic Findings of GCA Are usually present  Headache, temporal and scalp tenderness  Jaw claudication  Malaise, anorexia, weight loss, fever, joint & muscle pain  Ear pain

7. AAION Sever visual loss Pale edema Cotton wool spot F.A. delayed choroidal filling Normal cup.

9. Treating AAION Immediate therapy is critical Temporal artery biopsy may delayed treat IV prednisolone 1 g/day for 3-5 days Then oral prednisolone 100 mg/day tapered 3-12 month or more

10. Major Goals of Therapy Prevent contralateral visual loss Fellow eye involved 95% days or weeks Affected eye improve somewhat Avoid systemic vascular complication Risk of recurrence is 7% so tapering must be slow and careful

11. Nonarteritic Anterior ISchemic Optic Neuropathy (NAION) More common 90-95% of AION In younger age groups (mean age 60yr) Related to optic disc microcirculation On awakening, noctural systemic Hypotension Systemic symptoms are absent

13. NAION V.A. > 20/200 in over 60% of cases Palor is less common Optic disk in other eye is small and small or absent cup. 5 yr risk of other eye is 14.7% (psued- foster kennedy syd)

15. Risk Factors of NAION Crowding of disk (disk at risk) Systemic hypertension Diabetes (young) Smoking, hyperlipidemia Hyperhomocysteinemia, platelet polymorphism, sleep apnea Phosphodiestrase inhibitors (sildenafil or viagra) ?? Hypotensive effect

16. Differential Diagnosis of NAION Optic neuritis Infiltrative optic neuropathies Anterior orbital lesion Diabetic papillopathy

18. <40>50Age 92%+Unusualpain APD+ Pupil CentralAltitudinalVF Edema 33% hyperemic Edema 100% pale Optic disk UnusualCommonRetinal hemorrhage No delayedDelayed disk filling F.A. enhancementNo optic nereve enhancement MRI NAIONOptic neurtis

20. Treatment of NAION Untreated case remain stable but recovery of 3 lines 31% after 2 years Recurrence unusual 6.4% No proven therapy surgery no benefit No proven prophylaxis Asprin reducing incidence of fellow eye is unclear

22. 60 yrMean 70 yrAge F=MF>MSex NoneHeadache …Symptoms >20/200 60%<20/200 60%VA Small cup Hyperemic edema Normal cup pale edema Fundus Mean 20-40mm/hrMean 70mm/hrESR NormalElevatedC.R.P. 31% improved 12-19% fellow eye Rarely improved 54-95% fellow eye Natural history None provenSystemic steroidstreatment summary